Abbott funds research on CGM-nutrition connection 

ABBOTT PARK, Ill., and ARLINGTON, Va. – Abbott is providing a $2.65 million grant over the next three years to the American Diabetes Association to enable the ADA to, among other things, launch two pilot programs targeted at adults with Type 2 diabetes to gain a deeper understanding of the role a continuous glucose monitoring (CGM) system can play in personalized therapeutic nutrition. 

These programs will leverage CGM data to understand how they help people with diabetes achieve their objectives, which include modifications to their nutritional intake and dietary habits. 

"Abbott’s FreeStyle Libre technology can be a critical tool for all people living with diabetes, not only those on insulin," said Robert B. Ford, chairman and CEO, Abbott. "We look forward to working with the American Diabetes Association to gather further evidence to show how the technology we designed to be affordable and accessible can provide personalized insights to help people make informed decisions about their food and activity." 

The grant will also allow the ADA to: 

• Engage with top health care professionals and key opinion leaders to evaluate existing clinical evidence on the use of CGM systems for personalized, therapeutic nutrition. 
• Host roundtable discussions in collaboration with renowned health care experts to review and evaluate the existing clinical evidence. These discussions will investigate the role of therapeutic nutrition using CGM data and its potential to inform nutrition recommendations. 

"What people with diabetes eat is a critical part of managing their diabetes," said Charles "Chuck” Henderson, CEO of the ADA. "Personalized nutrition using CGMs has the potential to revolutionize diabetes management by providing individuals with more data and tools to manage their glucose levels, improve their quality of life, and reduce the risk of diabetes-related complications. The ADA is grateful to Abbott for its continued support of our mission to improve the lives of people impacted by diabetes." 

Abbott and the ADA have worked together for more than 20 years to fight for those affected by diabetes.